Cough Syrup Deaths In Gambia Hits A Key Growth Area For India
ndtv.com
news
2022-10-21 05:45:00

Maiden executive Naresh Kumar Goyal declined to comment.New Delhi: Indian health authorities said on Wednesday they had halted all production of New Delhi-based Maiden Pharmaceuticals after a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.Known as a "pharmacy of the world", India supplies 45% of all generic medicines to Africa.The deaths of 69 children in Gambia - one of the worst such incidents involving drugs from India - have come as a blow to the industry whose exports more than doubled in the last decade to hit $24.
